Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From TearLab Corporation
Private Company Edition: VC mega-rounds boosted the Q1 2021 total. Also, new funds from Versant, The Column Group and Rapha Capital keep cash flowing into biopharma; up to $525m is invested in Exscientia; and Arch Oncology and Boundless Bio raised $105m each, while Forge brought in $120m.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced April-May 2016.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in May 2016.
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
In Vitro Diagnostics
- Chemistry, Immunoassay
- Nanotechnology, Chips, etc.
- Other Names / Subsidiaries
- SOLX, Inc.
- Occulogix, Inc.